DNER
Delta and Notch-like epidermal growth factor-related receptor
Also known as: bet, DNER_HUMAN, UNQ26
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFT8
- Gene
- DNER
- Ensembl
- ENSG00000187957
- Chromosome
- 2
- Canonical length
- 737 aa
- Protein class
- Cancer-related genes, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable Notch binding activity. Involved in central nervous system development. Located in dendrite; early endosome; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
737 residues, UniProt reviewed canonical sequence.
>Q8NFT8|DNER
1 MQPRRAQAPG AQLLPALALL LLLLGAGPRG SSLANPVPAA PLSAPGPCAA QPCRNGGVCT
61 SRPEPDPQHP APAGEPGYSC TCPAGISGAN CQLVADPCAS NPCHHGNCSS SSSSSSDGYL
121 CICNEGYEGP NCEQALPSLP ATGWTESMAP RQLQPVPATQ EPDKILPRSQ ATVTLPTWQP
181 KTGQKVVEMK WDQVEVIPDI ACGNASSNSS AGGRLVSFEV PQNTSVKIRQ DATASLILLW
241 KVTATGFQQC SLIDGRSVTP LQASGGLVLL EEMLALGNNH FIGFVNDSVT KSIVALRLTL
301 VVKVSTCVPG ESHANDLECS GKGKCTTKPS EATFSCTCEE QYVGTFCEEY DACQRKPCQN
361 NASCIDANEK QDGSNFTCVC LPGYTGELCQ SKIDYCILDP CRNGATCISS LSGFTCQCPE
421 GYFGSACEEK VDPCASSPCQ NNGTCYVDGV HFTCNCSPGF TGPTCAQLID FCALSPCAHG
481 TCRSVGTSYK CLCDPGYHGL YCEEEYNECL SAPCLNAATC RDLVNGYECV CLAEYKGTHC
541 ELYKDPCANV SCLNGATCDS DGLNGTCICA PGFTGEECDI DINECDSNPC HHGGSCLDQP
601 NGYNCHCPHG WVGANCEIHL QWKSGHMAES LTNMPRHSLY IIIGALCVAF ILMLIILIVG
661 ICRISRIEYQ GSSRPAYEEF YNCRSIDSEF SNAIASIRHA RFGKKSRPAM YDVSPIAYED
721 YSPDDKPLVT LIKTKDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DNER can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 145 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 145 nTPM
- midbrain: 122 nTPM
- hypothalamus: 112 nTPM
- cerebral cortex: 97 nTPM
- spinal cord: 89 nTPM
- amygdala: 80 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 644 nCPM
- choroid plexus epithelial cells: 572 nCPM
- corticotrophs: 568 nCPM
- salivary acinar cells: 389 nCPM
- retinal amacrine cells: 371 nCPM
- oligodendrocytes: 349 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 282 nTPM
- choroid plexus: 277 nTPM
- cerebellum: 267 nTPM
- white matter: 259 nTPM
- hypothalamus: 249 nTPM
- spinal cord: 236 nTPM
ReferencesPubMed · IEDB
Publications for DNER from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
2014 · JAMA Neurol · RCR 1.3 · 39 citations - Favorable Outcomes in a Case of Non-paraneoplastic DNER Ataxia Treated with Immunotherapy.
2024 · Cerebellum
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.19
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- central nervous system development
- endocytosis
- glial cell differentiation
- neuron migration
- Notch receptor processing
- Notch signaling pathway
- skeletal muscle fiber development
- synapse assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-type aspartate/asparagine hydroxylation site
- EGF-like domain
- EGF-like calcium-binding domain
- Growth factor receptor cysteine-rich domain superfamily
- EGF-like, conserved site
- EGF-like calcium-binding, conserved site
- EGF-like domain
- Human growth factor-like EGF
- Delta and Notch-like epidermal growth factor-related receptor, C-terminal
- Delta and Notch-like EGF-related receptor C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DNER in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DNER as an antibody target. Whether an autoantibody or antibody against DNER could matter depends on whether native DNER is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DNER is annotated at the cell surface, where native DNER is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label DNER as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...